Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer (Q37633814)
Jump to navigation
Jump to search
scientific article published on 15 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer |
scientific article published on 15 March 2013 |
Statements
1 reference
Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer (English)
1 reference
Colin P N Dinney
1 reference
Mark B Fisher
1 reference
Neema Navai
1 reference
Michael A O'Donnell
1 reference
David Cutler
1 reference
Alice Abraham
1 reference
Sophia Young
1 reference
Beth Hutchins
1 reference
Maria Caceres
1 reference
Narendra Kishnani
1 reference
George Sode
1 reference
Constance Cullen
1 reference
Guangcheng Zhang
1 reference
H Barton Grossman
1 reference
Ashish M Kamat
1 reference
Marshall Gonzales
1 reference
Michael Kincaid
1 reference
Nancy Ainslie
1 reference
Daniel C Maneval
1 reference
Matthew F Wszolek
1 reference
William F Benedict
1 reference
15 March 2013
1 reference
1 reference
850-856
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference